Abstract: A lithium secondary battery has small internal resistance and has good charge-discharge cycle characteristics, with a lithium transition metal compound being used as a positive active material. A portion of transition element Me, which comprises Ni, Co or both Ni and Co, in a lithium transition metal compound LiMeO2 to be used as a positive active material is substituted for with at least two elements selected from among Ti, Li and Mn. The compound also corresponds to the formula LiMz(NiX1CoX2)1-ZO2, in which: 0?X1?1; 0?X2?1; X1+X2=1; M comprises at least two elements selected from among Ti, Li and Mn; and 0<Z<1.

Abstract: A method of fattening fowls comprising the step of administrating one or more running neuron inhibitory substance(s) is provided. Especially, a method of fattening fowls is provided, wherein fowls are administrated by a substance selected from the group consisting of GABAB receptor agonist, GABAA receptor agonist, GABAA receptor enhancer, kainate receptor antagonist and a combination thereof or fowls are provide with a feed comprising the substance or a combination thereof.

Abstract: A lithium secondary battery superior in the suppression of increasing internal resistance ratio and discharge capacity maintenance ratio and being simple in structure and inexpensive. A lithium secondary battery comprises a positive active material comprising a lithium aluminum manganese oxide having a spinel structure and an aluminum compound other than the lithium aluminum manganese oxide. A ratio of an amount of aluminum contained in the aluminum compound to a total amount of aluminum contained in the positive active material is within a range of 1% by weight or more to 50% by weight or less. The lithium aluminum manganese oxide is represented by a general formula Li1+xAlyMn2−x−yO4, wherein x and y denote constituting ratios of elements in one molecule, x≧0, y≧0.01, and has a lattice constant of 8.245 Å or less. A part of Mn may be replaced with an element other than Li and Al.

Abstract: A lithium secondary battery using a lithium manganese oxide for a positive active material having a cubic spinel structure which has a crystallite size of 58 nm or greater and/or a lattice distortion of 0.09% or less. The ratio of Li/Mn in the lithium manganese oxide is preferably greater than 0.5. In synthesizing the lithium manganese oxide, a mixed compound including salts and/or oxides of each of the elements is fired in an oxidizing atmosphere in a range of 650° C. to 1000° C. for 5 to 50 hours, with the properties of the crystal being improved by firing two or more times, preferably with an increase in firing temperature over the temperature of the previous firing.

Abstract: A lithium secondary battery includes: an electrode body having a positive electrode, a negative electrode, and a separator, the positive electrode and the negative electrode being wound or laminated by means of the separator; and a nonaqueous electrolyte solution containing a lithium compound as a electrolyte.

Abstract: The present invention provides a pharmaceutical composition and a method for prevent problem behaviors of animals, particularly companion animals. The pharmaceutical composition comprises one or more running neuron inhibiting substances, such as GABAB receptor agonists, GABAA receptor agonists, substances that enhance the activity of GABAA receptor and kainate receptor antagonists, or any combination thereof. The method comprises the step of administrating the pharmaceutical composition of the present invention.

Abstract: A lithium secondary battery using lithium manganese oxide as a positive active material and having excellent charge and discharge cycle properties.

Abstract: A lithium secondary battery has small internal resistance and has good charge-discharge cycle characteristics, with a lithium transition metal compound being used as a positive active material. A portion of transition element Me in a lithium transition metal compound LiMexOy to be used as a positive active material is substituted by not less than two kinds selected from the group consisting of Li, Fe, Mn, Ni, Mg, Zn, B, Al, Co, Cr, Si, Ti, Sn, P, V, Sb, Nb, Ta, Mo, and W. Here, M represents substitution elements, and M≢Me.

Abstract: A lithium secondary battery using a lithium manganese oxide for a positive active material having a cubic spinel structure which has a crystallite size of 58 nm or greater and/or a lattice distortion of 0.09% or less. The ratio of Li/Mn in the lithium manganese oxide is preferably greater than 0.5. In synthesizing the lithium manganese oxide, a mixed compound including salts and/or oxides of each of the elements is fired in an oxidizing atmosphere in a range of 650° C. to 1000° C. for 5 to 50 hours, with the properties of the crystal being improved by firing two or more times, preferably with an increase in firing temperature over the temperature of the previous firing.

Abstract: It is an object of the present invention to treat a patient suffering from symptoms accompanied by non-intentional motions such as poriomania and hyperkinesia, by administering to the patient a substance capable of pre-synaptically or post-synaptically inhibiting the running neurons. In particular, the running neuron-inhibitory substances include a member selected from the group consisting of kainate receptor antagonists, GABAB receptor agonists, GABAA receptor agonists, and GABAA receptor-enhancing substances, or any combination thereof.

Abstract: A lithium secondary battery has small internal resistance and has good charge-discharge cycle characteristics, with a lithium transition metal compound being used as a positive active material. A portion of transition element Me in a lithium transition metal compound LiMeXOY to be used as a positive active material is substituted by not less than two substitution elements M selected from the group consisting of Li, Fe, Mn, Ni, Mg, Zn, B, Al, Co, Cr, Si, Ti, Sn, P, V, Sb, Nb, Ta, Mo, and W. To provide LiMZMeN-ZOY wherein M≠Me .

Abstract: An amino acid and/or a peptide are orally administrated to a neonatal ruminant whose fermenting function of the rumen has not yet developed thereby effecting a significant increase in the accumulation of fat between the muscle fibers as well as increase of the fattening effect during the fattening period.

Abstract: It is an object of the present invention to provide a pharmaceutical composition, which permits the inhibition of non-intentional motions such as poriomania and hyperkinesia without any inhibition of intentional motions and in particular to provide a pharmaceutical composition capable of treating patients suffering from, for instance, poriomania and hyperkinesia. Moreover, it is also an object of the present invention to provide a method of using running neuron-inhibitory substances.

Abstract: The magnetic head assembly including a magnetic head having a terminal composed of a conductive film and a supporting spring. The supporting spring has interconnecting patterns (lines) on the top thereof and a projective electrode. The terminal of the magnetic head is electrically connected to the projective electrode of the supporting spring by a solderless, direct contact connection. The magnetic head is fixed to the supporting spring by using a non-electrical bonding agent. This structure makes it possible to stabilize the position of the magnetic head assembly and the relative speed variation between the magnetic head element and the magnetic disk, thereby enhancing the reliability of the magnetic disk apparatus.

Abstract: In AlN crystal grains constituting a sintered body, is contained: 150 ppm-0.5 wt. %, preferably at most 0.1 wt.%, of at least one rare earth element (as oxide thereof); at most 900 ppm, preferably at most 500 ppm of at least one metal impurity except rare earth elements; and preferably at least 0.5 wt. % of oxygen measured by an electron probe X-ray microanalyzer. The grains have an average grain diameter of preferably at least 3.0 .mu.m and show a main peak in the wavelength range of 350-370 nm of spectrum obtained by a cathode luminescence method. The sintered body composed of AlN crystal grains has a volume resistivity at room temperature of at most 1.0.times.10.sup.12 .OMEGA..multidot.cm.

Abstract: A cleavage promoting agent comprising as an effective ingredient at least one of the polypeptides BUF-3, BUF-4 and BUF-5 is useful for the treatment of fertilized or unfertilized ova in order to promote cell division and improve reproduction efficiency.

Abstract: The present invention relates to a multi-pin chip mounting method and apparatus based on a TAB (Tape Automated Bonding) system in which leads formed on a tape and bumps formed an IC chip are aligned with each other and compress-bonded to each other. An IC chip having bumps formed on a surface thereof and inner leads formed on a carrier tape are disposed opposite to each other at a bonding station. A position of the IC chip on a stage is detected through the inner leads at the bonding station to determine the amount of correction of position of the stage. The inner leads and the IC chip are aligned with each other on the basis of the determined correction amount and are thereafter bonded to each other.

Abstract: A transfer device is provided with a cleaning unit having a magnetic brush roller and functions to electrostatically transfer a toner image on an image carrier to a transfer material held on a dielectric body. The device has a transfer charger for applying DC electric field to the portion of the dielectric body opposite to the image carrier during transfer so that the toner image on the image carrier is transferred to the transfer material. The device also has means for applying AC voltage to the transfer charger within a given time during non-transfer, and a DC charger for applying DC electric field with the same polarity as that of the toner particles frictionally electrified to the surface of the dielectric body at least within a given time.

Abstract: As a die bonding apparatus for establishing electrical connection between electrodes on one side of a semiconductor chip and associated electrodes on a package comprises a pair of pinching and pressing mechanisms having a pair of pinching and pressing surfaces adapted to be moved closer relative to each other and so as to pinch and press semiconductor chip and package and at least one remote center mechanism provided in at least one of the pair of pinching and pressing mechanisms, in such a manner that a remote center thereof is positioned in the pinching and pressing surface of above-mentioned one pinching and pressing mechanism, for adjusting orientations of the pair of pinching and pressing surfaces to make the orientations thereof correspond to those of both surfaces of the semiconductor chip and the package at the time of the pressing and pinching operation all of the electrodes on one side of the semiconductor chip are thereby uniformly pressed against the corresponding electrodes on the package without

Abstract: A segmentation apparatus utilized in an image processing system for recognizing a pattern in an image inputted thereto includes a separate circuit for outputting logical values of m by n pixels separated from the inputted image, an encode circuit for storing in advance therein codes to be determined according to the content of an inputted pattern and for outputting a code indicating that which set of pixels is identical to the objective pixel by using as an input pattern the logical value outputted from the separate circuit, and a select circuit for selecting a label of the objective label, from the label data of neighborhood pixels already determined and the new label data assigned, in accordance with the output from the encode circuit.